Clovis Oncology, Inc. CLVSQ

Market cap
$14.2M
P/E
0.0×
Growth Flags show if company had growth for consecutive years
Older periods Dec '21 Mar '22 Jun '22 Sep '22
ROE

+8 more TTM periods

120.90% 98.57% 91.63% 78.31%
ROA
(49.06%) (51.66%) (54.57%) (58.94%)
ROIC
(71.85%) (65.22%) (73.03%) 0.00%
Return on Tangible Assets
(333.04%) (370.81%) (997.42%) 39.31%
Average Days of Receivables
65.93 68.73 48.32 53.38
Free Cash Flow per Share
(1.70) (1.40) (1.26) (1.22)
Free Cash Flow
(196.37) (192.92) (181.30) (175.84)
Piotroski F-Score
3.00 4.00 2.00 2.00
Other line items

Show all line items

Columns are period end dates